1) Probably right.
2) Don't recall last week's as well, so we will have to wait for next week to verify if today is every other week boost.
3) Let's hope so.
4) Agree to a point. We are not generating any profits with U.S. as they are now. Now if we could keep 85K scripts and cut out all the overhead then yes it is helping us until the EU stuff comes in.
Things were supposed to get better for a number of reasons that were being given. Better insurance coverage for V/dropping of GV by some carriers, lack of API for Generics, fear of impending lawsuit and possibility of treble damages, GSK-Teva verdict, etc. So far we aren't seeing the benefits of those postulates.
Market Data 
Markets 
AI
